Reference List: Albuterol

Albuterol

Drugs for asthma. Med Lett Drugs Ther. 1999;41:5-10.

Bradding P, Rushby I, Scullion J, Morgan MD. As-required versus regular nebulized salbutamol for the treatment of acute severe asthma. Eur Respir J. 1999;13:290-4.

Campbell S. For COPD a combination of ipratropium bromide and albuterol sulfate is more effective than albuterol base. Arch Intern Med. 1999;159:156-60.

Emerman CL, Cydulka RK, McFadden ER. Comparison of 2.5 vs 7.5 mg of inhaled albuterol in the treatment of acute asthma. Chest. 1999;115:92-6.

Friedman M, Serby CW, Menjoge SS, et al. Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD. Chest. 1999;115:635-41.

Hung CH, Chu DM, Wang CL, Yang KD. Hypokalemia and salbutamol therapy in asthma. Pediatr Pulmonol. 1999;27:27-31.

Kaczka DW, Ingenito EP, Israel E, Lutchen KR. Airway and lung tissue mechanics in asthma. Effects of albuterol. Am J Respir Crit Care Med. 1999;159:169-78.

Lipworth BJ, Aziz I. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol. J Allergy Clin Immunol. 1999;103:88-92.

Mandelberg A, Krupnik Z, Houri S, et al. Salbutamol metered-dose inhaler with spacer for hyperkalemia: how fast? How safe? Chest. 1999;115:617-22.

Anderson PJ, Zhou X, Breen P, et al. Pharmacokinetics of (R,S)-Albuterol after aerosol inhalation in healthy adult volunteers. J Pharm Sci. 1998;87:841-4.

Benoit D, Vahdewoude K, Colardyn F. Effects of nebulized salbutamol in ARDS [letter; comment]. Intensive Care Med. 1998;24:88-9.

Berlinski A, Waldrep JC. Four hours of continuous albuterol nebulization. Chest. 1998;114:847-53.

Bleecker ER, Tinkelman DG, Ramsdell J, et al. Proventil HFA provides bronchodilation comparable to ventolin over 12 weeks of regular use in asthmatics. Chest. 1998;113:283-9.

Bondesson E, Friberg K, Soliman S, Lofdahl CG. Safety and efficacy of a high cumulative dose of salbutamol inhaled via Turbuhaler or via a pressurized metered-dose inhaler in patients with asthma. Respir Med. 1998;92:325-30.

Calvo GM, Calvo AM, Marin HF, Moya GJ. Is it useful to add an anticholinergic treatment to beta 2-adrenergic medication in acute asthma attack? J Investig Allergol Clin Immunol. 1998;8:30-4.

Can D, Inan G, Yendur G, et al. Salbutamol or mist in acute bronchiolitis. Acta Paediatr Jpn. 1998;40:252-5.

Cazzola M, Di Perna F, Noschese P. Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD. Eur Respir J. 1998;11:1337-41.

Chang AB, Phelan PD, Carlin JB, Sawyer SM, Robertson CF. A randomised, placebo controlled trial of inhaled salbutamol and beclomethasone for recurrent cough. Arch Dis Child. 1998;79:6-11.

Congleton J, Muers MF. Effect of regular use of high-dose nebulized beta2-agonists on resting energy expenditure, weight, and handgrip strength in patients with chronic airflow limitation. Chest. 1998;113:1588-94.

Corden Z, Rees PJ. The effect of oral corticosteroids on bronchodilator responses in COPD. Respir Med. 1998;92:279-82.

Corne JM, Linaker CH, Howarth PH, et al. Effect of systemic beta-agonist therapy on IgE production in allergic subjects in vivo. J Allergy Clin Immunol. 1998;102:727-31.

Creutzberg EC, Schols AM, Bothmer-Quaedvlieg FC, et al. Acute effects of nebulized salbutamol on resting energy expenditure in patients with chronic obstructive pulmonary disease and in healthy subjects. Respiration. 1998;65:375-80.

de Benedictis FM, Tuteri G, Pazzelli P, et al. Combination drug therapy for the prevention of exercise-induced bronchoconstriction in children. Ann Allergy Asthma Immunol. 1998;80:352-6.

De Boeck K, Smith J, Van Lierde S, Devlieger H. Response to bronchodilators in clinically stable 1-year-old patients with bronchopulmonary dysplasia. Eur J Pediatr. 1998;157:75-9.

Denjean A, Paris-Llado J, Zupan V, et al. Inhaled salbutamol and beclomethasone for preventing bronchopulmonary dysplasia: a randomised double-blind study. Eur J Pediatr. 1998;157:926-31.

Derish M, Hodge G, Dunn C, Ariagno R. Aerosolized albuterol improves airway reactivity in infants with acute respiratory failure from respiratory syncytial virus. Pediatr Pulmonol. 1998;26:12-20.

Dobson JV, Stephens-Groff SM, McMahon SR, et al. The use of albuterol in hospitalized infants with bronchiolitis. Pediatrics. 1998;101:361-8.

Ducharme FM, Davis GM. Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma. J Pediatr. 1998;133:479-85.

Ezeamuzie CI, al-Hage M. Differential effects of salbutamol and salmeterol on human eosinophil responses. J Pharmacol Exp Ther. 1998;284:25-31.

Groeben H, Silvanus MT, Beste M, Peters J. Combined intravenous lidocaine and inhaled salbutamol protect against bronchial hyperreactivity more effectively than lidocaine or salbutamol alone. Anesthesiology. 1998;89:862-8.

Gross N, Tashkin D, Miller R, et al. Inhalation by nebulization of albuterol-ipratropium combination (Dey combination) is superior to either agent alone in the treatment of chronic obstructive pulmonary disease. Respiration. 1998;65:354-62.

Kargul B, Tanboga I, Ergeneli S, et al. Inhaler medicament effects on saliva and plaque pH in asthmatic children. J Clin Pediatr Dent. 1998;22:137-40.

Kemp J, Wolfe J, Grady J, et al. Salmeterol powder compared with albuterol aerosol as maintenance therapy for asthma in adolescent and adult patients. Clin Ther. 1998;20:270-82.

Konig P, Poehler J, Barbero GJ. A placebo-controlled, double-blind trial of the long-term effects of albuterol administration in patients with cystic fibrosis. Pediatr Pulmonol. 1998;25:32-6.

Lanes SF, Garrett JE, Wentworth CE 3rd. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials. Chest. 1998;114:365-72.

Langley SJ, Masterson CM, Batty EP, Woodcock A. Bronchodilator response to salbutamol after chronic dosing with salmeterol or placebo. Eur Respir J. 1998;11:1081-5.

Lin RY, Pesola GR, Bakalchuk L, et al. Superiority of ipratropium plus albuterol over albuterol alone in the emergency department management of adult asthma: a randomized clinical trial. Ann Emerg Med. 1998;31:208-13.

McFadden ER Jr, Strauss L, Hejal R, et al. Comparison of two dosage regimens of albuterol in acute asthma. Am J Med. 1998;105:12-7.

Nelson HS, Bensch G, Pleskow WW, et al. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma. J Allergy Clin Immunol. 1998;102:943-52.

Pillet O, Manier G, Castaing Y. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients. Monaldi Arch Chest Dis. 1998;53:3-8.

Planquois JM, Mottin G, Artola M, et al. Effects of phosphodiesterase inhibitors and salbutamol on microvascular leakage in guinea-pig trachea. Eur J Pharmacol. 1998;344:59-66.

Podczeck F. Evaluation of the adhesion properties of salbutamol sulphate to inhaler materials. Pharm Res. 1998;15:806-8.

Polosa R, Prosperini G, Magri S. Bronchodilator response to salbutamol after spontaneous recovery from nonspecific bronchial provocation tests in asthma. Eur Respir J. 1998;11:1086-90.

Rakhmanina NY, Kearns GL, Farrar HC 3rd. Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler. Pediatr Emerg Care. 1998;14:145-7.

Rodrigo C, Rodrigo G. Therapeutic response patterns to high and cumulative doses of salbutamol in acute severe asthma. Chest. 1998;113:593-8.

Rossinen J, Partanen J, Stenius-Aarniala B, Nieminen MS. Salbutamol inhalation has no effect on myocardial ischaemia, arrhythmias and heart-rate variability in patients with coronary artery disease plus asthma or chronic obstructive pulmonary disease. J Intern Med. 1998;243:361-6.

Sandsund M, Sue-Chu M, Helgerud J, et al. Effect of cold exposure (-15 degrees C) and salbutamol treatment on physical performance in elite nonasthmatic cross-country skiers. Eur J Appl Physiol. 1998;77:297-304.

Tantucci C, Duguet A, Similowski T, et al. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. Eur Respir J. 1998;12:799-804.

Tinkelman DG, Bleecker ER, Ramsdell J, et al. Proventil HFA and ventolin have similar safety profiles during regular use. Chest. 1998;113:290-6.

Van Der Heijden HF, Zhan WZ, Prakash YS. Salbutamol enhances isotonic contractile properties of rat diaphragm muscle. J Appl Physiol. 1998;85:525-9.

Wenzel SE, Lumry W, Manning M, et al. Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma. Ann Allergy Asthma Immunol. 1998;80:463-70.

Wildhaber JH, Hayden MJ, Dore ND, et al. Salbutamol delivery from a hydrofluoroalkane pressurized metered-dose inhaler in pediatric ventilator circuits: an in vitro study. Chest. 1998;113:186-91.

Baker EK, Willsie SK, Marinac JS, Salzman GA. Continuously nebulized albuterol in severe exacerbations of asthma in adults: a case-controlled study. J Asthma. 1997;34:521-30.

Baker ER, Flanagan MF. Fetal atrial flutter associated with maternal beta-sympathomimetic drug exposure. Obstet Gynecol. 1997;89:861.

Barry PW, O'Callaghan C. In vitro comparison of the amount of salbutamol available for inhalation from different formulations used with different spacer devices. Eur Respir J. 1997;10:1345-8.

Bennett J, Tattersfield AE. Several studies have shown salmeterol to be more potent than salbutamol for systemic effects [letter; comment]. BMJ. 1997;315:121.

Bennett JA, Tattersfield AE. Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects. Thorax. 1997;52:458-64.

Boothman-Burrell D, Jones D, et al. The effect of regular salbutamol on lung function and bronchial hyperresponsiveness in normal subjects and nonasthmatic atopic subjects with allergic rhinitis. Chest. 1997;112:12-8.

Boulet LP, Laviolette M, Boucher S, et al. A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: a Canadian multicenter study. J Allergy Clin Immunol. 1997;99:13-21.

Boulton DW, Fawcett JP. Pharmacokinetics and pharmacodynamics of single oral doses of albuterol and its enantiomers in humans. Clin Pharmacol Ther. 1997;62:138-44.

Browne GJ, Penna AS, Phung X, Soo M. Randomised trial of intravenous salbutamol in early management of acute severe asthma in children. Lancet. 1997;349:301-5.

Carlsen KH, Ingjer F, Kirkegaard H, Thyness B. The effect of inhaled salbutamol and salmeterol on lung function and endurance performance in healthy well-trained athletes. Scand J Med Sci Sports. 1997;7:160-5.

Chapman KR, Friberg K, Balter MS, et al. Albuterol via Turbuhaler versus albuterol via pressurized metered- dose inhaler in asthma. Ann Allergy Asthma Immunol. 1997;78:59-63.

Choi JH, Rooke GA, Wu SC, Bishop MJ. Reduction in post-intubation respiratory resistance by isoflurane and albuterol. Can J Anaesth. 1997;44:717-22.

Chua S, Razvi K, Wong MT, et al. Is there a need to treat hypokalaemia associated with intravenous salbutamol infusion? J Obstet Gynaecol Res. 1997;23:381-7.

Clark DJ, Lipworth BJ. Dose-response of inhaled drugs in asthma. An update. Clin Pharmacokinet. 1997;32:58-74.

Cockcroft DW, Swystun VA. Effect of single doses of S-salbutamol, R-salbutamol, racemic salbutamol, and placebo on the airway response to methacholine. Thorax. 1997;52:845-8.

COMBIVENT Inhalation Solution Study Group. Routine nebulized ipratropium and albuterol together are better than either alone in COPD . Chest. 1997;112:1514-21.

Crowther SD, Morley J, Costello JF. Varied effects of regular salbutamol on airway responsiveness to inhaled spasmogens [letter]. Lancet. 1997;350:1450.

Dagnone AJ, Parlow JL. Effects of inhaled albuterol and ipratropium bromide on autonomic control of the cardiovascular system. Chest. 1997;111:1514-8.

Diaz JE, Dubin R, Gaeta TJ, et al. Efficacy of atropine sulfate in combination with albuterol in the treatment for acute asthma. Acad Emerg Med. 1997;4:107-13.

Dockhorn RJ, Wagner DE, Burgess GL, et al. Proventil HFA provides protection from exercise-induced bronchoconstriction comparable to proventil and ventolin. Ann Allergy Asthma Immunol. 1997;79:85-8.

Emerman CL, Cydulka RK. Effect of different albuterol dosing regimens in the treatment of acute exacerbation of chronic obstructive pulmonary disease. Ann Emerg Med. 1997;29:474-8.

Esquisabel A, Hernandez RM, Gascon AR, et al. Determination of salbutamol enantiomers by high-performance capillary electrophoresis and its application to dissolution assays. J Pharm Biomed Anal. 1997;16:357-66.

Finkelstein F. Isoetherine or albuterol for acute asthma [letter; comment]. Am J Med. 1997;102:130.

Fok TF, Al-Essa M, Monkman S, et al. Pulmonary deposition of salbutamol aerosol delivered by metered dose inhaler, jet nebulizer, and ultrasonic nebulizer in mechanically ventilated rabbits. Pediatr Res. 1997;42:721-7.

Gappa M, Gartner M, Poets CF, von der Hardt H. Effects of salbutamol delivery from a metered dose inhaler versus jet nebulizer on dynamic lung mechanics in very preterm infants with chronic lung disease. Pediatr Pulmonol. 1997;23:442-8.

Garrett JE, Town GI, Rodwell P, Kelly AM. Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma. J Allergy Clin Immunol. 1997;100:165-70.

Gauvreau GM, Jordana M, Watson RM, et al. Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects. Am J Respir Crit Care Med. 1997;156:1738-45.

Goh A, Chay OM, Foo AL, Ong EK. Efficacy of bronchodilators in the treatment of bronchiolitis. Singapore Med J. 1997;38:326-8.

Govender T, Dangor CM. Formulation and preparation of controlled release pellets of salbutamol by the air suspension technique. J Microencapsul. 1997;14:445-55.

Gunawardena KA, Sohal T, Jones JI, et al. The Spacehaler for delivery of salbutamol: a comparison with the standard metered-dose inhaler plus Volumatic spacer device. Respir Med. 1997;91:311-6.

Hernandez RM, Gascon AR, Calvo MB, et al. Influence of route of administration and dosage form in the pharmacokinetics and bioavailability of salbutamol. Eur J Drug Metab Pharmacokinet. 1997;22:145-50.

Higham MA, Sharara AM, Wilson P, et al. Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma. Thorax. 1997;52:975-80.

Hindle M, Peers EM, Parry-Billings M, Chrystyn H. Relative bioavailability of salbutamol to the lung following inhalation via a novel dry powder inhaler and a standard metered dose inhaler. Br J Clin Pharmacol. 1997;43:336-8.

Ind PW. Salbutamol enantiomers: early clinical evidence in humans [editorial; comment]. Thorax. 1997;52:839-40.

Jacobson GA, Peterson GM, McLean S. Investigation of urinary levels of salbutamol in asthmatic patients receiving inhaled therapy. J Clin Pharm Ther. 1997;22:119-26.

Jartti T, Kaila T, Tahvanainen K, et al. The acute effects of inhaled salbutamol on the beat-to-beat variability of heart rate and blood pressure assessed by spectral analysis. Br J Clin Pharmacol. 1997;43:421-8.

Kemp JP, Hill MR, Vaughan LM, et al. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler. Ann Allergy Asthma Immunol. 1997;79:322-6.

Kim HJ. Acute therapy for hyperkalemia with the combined regimen of bicarbonate and beta(2)-adrenergic agonist (salbutamol) in chronic renal failure patients. J Korean Med Sci. 1997;12:111-6.

Konradova V, Uhlik J, Vajner L, Zocova J. Effect of an adrenergic agonist and a cholinergic antagonist on the airway epithelium. Vet Med (Praha). 1997;42:289-93.

Kraemer R, Graf Bigler U, Casaulta Aebischer C, et al. Clinical and physiological improvement after inhalation of low-dose beclomethasone dipropionate and salbutamol in wheezy infants. Respiration. 1997;64:342-9.

Laurikainen K, Silvasti M, Calderon P, et al. Comparison of bronchodilating effects of two salbutamol dry powder inhalers in asthmatic patients. Arzneimittelforschung. 1997;47:44-6.

Lipworth BJ, Clark DJ. Lung delivery of salbutamol by dry powder inhaler (Turbuhaler) and small volume antistatic metal spacer (Airomir CFC-free MDI plus NebuChamber). Eur Respir J. 1997;10:1820-3.

Lipworth BJ, Clark DJ, Koch P, Arbeeny C. Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers. Thorax. 1997;52:849-52.

Lofdahl CG, Andersson L, Bondesson E, et al. Differences in bronchodilating potency of salbutamol in Turbuhaler as compared with a pressurized metered-dose inhaler formulation in patients with reversible airway obstruction. Eur Respir J. 1997;10:2474-8.

MacNeish CF, Meisner D, Thibert R, et al. A comparison of pulmonary availability between Ventolin (albuterol) nebules and Ventolin (albuterol) Respirator Solution. Chest. 1997;111:204-8.

Maury E, Ioos V, Lepecq B, et al. A paradoxical effect of bronchodilators. Chest. 1997;111:1766-7.

Millar EA, Connell JM, Thomson NC. The effect of nebulized albuterol on the activity of the renin-angiotensin system in asthma. Chest. 1997;111:71-4.

Morina P, Herrera M, Venegas J, et al. Effects of nebulized salbutamol on respiratory mechanics in adult respiratory distress syndrome. Intensive Care Med. 1997;23:58-64.

Munoz-Rodriguez FJ, Font J, Badia JR, et al. Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapy. Lupus. 1997;6:412-4.

Nogami-Itoh M, Yakuo I, Hammerbeck DM, et al. The equivalent bronchodilator effects of salbutamol formulated in chlorofluorocarbon and hydrofluoroalkane-134a metered dose inhalers on the histamine-induced pulmonary response in dogs. Pharm Res. 1997;14:208-12.

Plaut TF, Westby L. A minimal response to albuterol challenge does not exclude a diagnosis of asthma. J Asthma. 1997;34:255-6.

Prevost A, Leperre A, Moreau F, et al. Cardiotoxic effects of salmeterol in comparison with salbutamol on the isolated perfused Langendorff-heart of the rat. Arzneimittelforschung. 1997;47:39-43.

Raimondi AC, Schottlender J, Lombardi D, Molfino NA. Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder. Chest. 1997;112:24-8.

Rihmer Z. Successful treatment of salbutamol-induced panic disorder with citalopram. Eur Neuropsychopharmacol. 1997;7:241-2.

Ritz M, Thorens JB, Arnold-Ketterer M, Chevrolet JC. Effects of inhaled salmeterol and salbutamol (albuterol) on morning dips compared in intensive care patients recovering from an acute severe asthma attack. Intensive Care Med. 1997;23:1225-30.

Semmekrot BA, Monnens LA. A warning for the treatment of hyperkalaemia with salbutamol [letter; comment]. Eur J Pediatr. 1997;156:420.

Strauss L, Hejal R, Galan G. Observations on the effects of aerosolized albuterol in acute asthma. Am J Respir Crit Care Med. 1997;155:454-8.

Suissa S, Ernst P. Albuterol in mild asthma [letter; comment]. N Engl J Med. 1997;336:729.

Taylor DA, Jensen MW, Aikman SL, et al. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma. Am J Respir Crit Care Med. 1997;156:1731-7.

van der Heijden HF, Dekhuijzen PN, Folgering H, van Herwaarden CL. Inotropic effects of salbutamol on rat diaphragm contractility are potentiated by foreshortening. Am J Respir Crit Care Med. 1997;155:1072-9.

Williamson IJ, Reid A, Monie RD, et al. Generic inhaled salbutamol versus branded salbutamol. A randomised double-blind study. Postgrad Med J. 1997;73:156-8.

Zahger D. Albuterol in mild asthma [letter; comment]. N Engl J Med. 1997;336:729-30.

Altraja A, Laitinen A, Meriste S, et al. Effect of regular nedocromil sodium or albuterol on bronchial inflammation in chronic asthma. J Allergy Clin Immunol. 1996;98:S58-64.

Apter AJ, Reisine ST, Willard A, et al. The effect of inhaled albuterol in moderate to severe asthma. J Allergy Clin Immunol. 1996;98:295-301.

Bhagat R, Swystun VA, Cockcroft DW. Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response. J Allergy Clin Immunol. 1996;97:47-52.

Charoenratanakul S, Borrirukwanit K. Effect of salbutamol on oxygen saturation in COPD. J Med Assoc Thai. 1996;79:218-21.

Chrystyn H, Corlett SA, Silkstone V. Lung bioavailability of generic and innovator salbutamol MDIs [letter; comment]. Thorax. 1996;51:658.

Clark DJ, Gordon-Smith J, McPhate G, et al. Lung bioavailability of generic and innovator salbutamol metered dose inhalers. Thorax. 1996;51:325-6.

Clark DJ, Lipworth BJ. Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device. Thorax. 1996;51:981-4.

Craig TJ, Smits W, Soontornniyomkiu V. Elevation of creatine kinase from skeletal muscle associated with inhaled albuterol. Ann Allergy Asthma Immunol. 1996;77:488-90.

Craig VL, Bigos D, Brilli RJ. Efficacy and safety of continuous albuterol nebulization in children with severe status asthmaticus. Pediatr Emerg Care. 1996;12:1-5.

Dagg KD, Thomson LJ, Ramsay SG, Thomson NC. Effect of acute hyperoxia on the bronchodilator response to salbutamol in stable asthmatic patients. Thorax. 1996;51:853-4.

Daugbjerg P, Nielsen KG, Skov M, Bisgaard H. Duration of action of formoterol and salbutamol dry-powder inhalation in prevention of exercise-induced asthma in children. Acta Paediatr. 1996;85:684-7.

Desager KN, van Bever HP, Vermeire PA. Comparison of non-chlorofluorocarbon-containing salbutamol and conventional inhaler [letter]. Lancet. 1996;348:200-1.

Donateo L, Gerardi R, Cantini L. A new spacer device for administration of inhaled salbutamol: use in elderly asthmatics. Adv Ther. 1996;13:292-300.

Duarte AG, Dhand R, Reid R, et al. Serum albuterol levels in mechanically ventilated patients and healthy subjects after metered-dose inhaler administration. Am J Respir Crit Care Med. 1996;154:1658-63.

Garner SS, Wiest DB, Bradley JW, et al. Albuterol delivery by metered-dose inhaler in a mechanically ventilated pediatric lung model. Crit Care Med. 1996;24:870-4.

Gioulekas D, Papakosta D, Vordoyianni P, et al. A comparison of the clinical efficacy and patient acceptability of terbutaline Turbuhaler and salbutamol Rotahaler, in adult patients with asthma. Respir Med. 1996;90:205-9.

Hageman JR. What is continuous nebulized albuterol? J Perinatol. 1996;16:481-2.

Hordvik NL, Sammut PH, Judy CG, et al. The effects of albuterol on the lung function of hospitalized patients with cystic fibrosis. Am J Respir Crit Care Med. 1996;154:156-60.

Ikeda A, Nishimura K, Izumi T. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD [letter]. Chest. 1996;109:294.

Ingram RH Jr. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD [letter; comment]. Chest. 1996;109:293.

Inman MD, O'Byrne PM. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. Am J Respir Crit Care Med. 1996;153:65-9.

Karpel JP, Schacter EN, Fanta C, et al. A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma. Chest. 1996;110:611-6.

Khine H, Fuchs SM, Saville AL. Continuous vs intermittent nebulized albuterol for emergency management of asthma. Acad Emerg Med. 1996;3:1019-24.

Kleerup EC, Tashkin DP, Cline AC, Ekholm BP. Cumulative dose-response study of non-CFC propellant HFA 134a salbutamol sulfate metered-dose inhaler in patients with asthma. Chest. 1996;109:702-7.

Leblanc P, Knight A, Kreisman H, et al. A placebo-controlled, crossover comparison of salmeterol and salbutamol in patients with asthma. Am J Respir Crit Care Med. 1996;154:324-8.

Maki KC, Skorodin MS, Jessen JH, Laghi F. Effects of oral albuterol on serum lipids and carbohydrate metabolism in healthy men. Metabolism. 1996;45:712-7.

Man GC, Champman KR, Ali SH, Darke AC. Sleep quality and nocturnal respiratory function with once-daily theophylline (Uniphyl) and inhaled salbutamol in patients with COPD. Chest. 1996;110:648-53.

Masclans JR, Barbera JA, MacNee W. Salbutamol reduces pulmonary neutrophil sequestration of platelet- activating factor in humans. Am J Respir Crit Care Med. 1996;154:529-32.

Meral A, Coker M, Tanac R. Inhalation therapy with magnesium sulfate and salbutamol sulfate in bronchial asthma. Turk J Pediatr. 1996;38:169-75.

Newhouse MT, Chapman KR, McCallum AL. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma. Chest. 1996;110:595-603.

Reggio S, Bustacchini S, Pistelli R, Valente S. Equivalence of pharmacokinetic characteristics and bronchodilating effect between two combined formulations of nedocromil sodium and salbutamol: MDI and nebulizer solution. Int J Clin Pharmacol Res. 1996;16:19-27.

Rusconi F, Sideri S. Efficacy of epinephrine with salbutamol in treatment of acute bronchiolitis [letter; comment]. J Pediatr. 1996;128:441-3.

Shrestha M, Bidadi K, Gourlay S, Hayes J. Continuous vs intermittent albuterol, at high and low doses, in the treatment of severe acute asthma in adults. Chest. 1996;110:42-7.

Shrestha M, Gourlay S, Robertson S, et al. Isoetharine versus albuterol for acute asthma: greater immediate effect, but more side effects. Am J Med. 1996;100:323-7.

Singhi SC, Jayashree K, Sarkar B. Hypokalaemia following nebulized salbutamol in children with acute attack of bronchial asthma. J Paediatr Child Health. 1996;32:495-7.

Skoner DP, Boltansky H, Kobayashi RH, et al. Extended-release albuterol in the treatment of 6- to 12-year-old asthmatic children. Ann Allergy Asthma Immunol. 1996;76:462-8.

Tal A, Golan H, Grauer N, et al. Deposition pattern of radiolabeled salbutamol inhaled from a metered- dose inhaler by means of a spacer with mask in young children with airway obstruction. J Pediatr. 1996;128:479-84.

Terzano C, Mannino F. Probability of particle and salbutamol deposition in the respiratory tract: comparison between MDI and Autohaler. Monaldi Arch Chest Dis. 1996;51:236-42.

Thomas K, Peter JV, Cherian AM, Guyatt G. Cost-effectiveness of inhaled beta-agonists v. oral salbutamol in asthma: a randomized double-blind cross-over study. Natl Med J India. 1996;9:159-62.

Van der Heijden HF, Van Balkom RH, Folgering HT, et al. Effects of salbutamol on rat diaphragm contractility. J Appl Physiol. 1996;81:1103-10.

Van Keimpema AR, Ariaansz M, Raaijmakers JA, et al. Treatment of nocturnal asthma by addition of oral slow-release albuterol to standard treatment in stable asthma patients. J Asthma. 1996;33:119-24.

Wildhaber JH, Devadason SG, Hayden MJ, et al. Electrostatic charge on a plastic spacer device influences the delivery of salbutamol. Eur Respir J. 1996;9:1943-6.

Aldrey OE, Anez H, Deibis L, et al. A double-blind, cross-over study using salbutamol, beclomethasone, and a combination of both in bronchial asthma. J Asthma. 1995;32:21-8.

Buck ML. Administration of albuterol by continuous nebulization. AACN Clin Issues. 1995;6:279-86.

Campbell IA, Colman SB, Mao JH, et al. An open, prospective comparison of beta 2 agonists given via nebuliser, Nebuhaler, or pressurised inhaler by ambulance crew as emergency treatment. Thorax. 1995;50:79-80.

Connolly MJ, Crowley JJ, Charan NB, et al. Impaired bronchodilator response to albuterol in healthy elderly men and women. Chest. 1995;108:401-6.

Dawson KP, Penna AC, Manglick P. Acute asthma, salbutamol and hyperglycaemia. Acta Paediatr. 1995;84:305-7.

Diot P, Morra L, Smaldone GC. Albuterol delivery in a model of mechanical ventilation. Comparison of metered-dose inhaler and nebulizer efficiency. Am J Respir Crit Care Med. 1995;152:1391-4.

Dockhorn R, Vanden Burgt JA, Ekholm BP, et al. Clinical equivalence of a novel non-chlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma. J Allergy Clin Immunol. 1995;96:50-6.

Everard ML, Devadason SG, Summers QA, Le Souef PN. Factors affecting total and "respirable" dose delivered by a salbutamol metered dose inhaler. Thorax. 1995;50:746-9.

Graham SJ, Lawrence RC, Ormsby ED, Pike RK. Particle size distribution of single and multiple sprays of salbutamol metered-dose inhalers (MDIs). Pharm Res. 1995;12:1380-4.

Hindle M, Newton DA, Chrystyn H. Dry powder inhalers are bioequivalent to metered-dose inhalers. A study using a new urinary albuterol (salbutamol) assay technique. Chest. 1995;107:629-33.

Holt WJ, Greenspan JS, Antunes MJ, et al. Pulmonary response to an inhaled bronchodilator in chronically ventilated preterm infants with suspected airway reactivity. Respir Care. 1995;40:145-51.

Ikeda A, Nishimura K, Koyama H, Izumi T. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone. Chest. 1995;107:401-5.

Jonkers RE, Koopmans RP. Beta 2 agonist/antagonist activity of salbutamol [letter; comment]. Thorax. 1995;50:1227-8.

Juniper EF, Johnston PR, Borkhoff CM, et al. Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol. Am J Respir Crit Care Med. 1995;151:66-70.

Keller KA, Bhisitkul DM. Supraventricular tachycardia: a complication of nebulized albuterol. Pediatr Emerg Care. 1995;11:98-9.

Konig P, Gayer D, Barbero GJ, Shaffer J. Short-term and long-term effects of albuterol aerosol therapy in cystic fibrosis: a preliminary report. Pediatr Pulmonol. 1995;20:205-14.

Manthous CA, Chatila W, Schmidt GA, Hall JB. Treatment of bronchospasm by metered-dose inhaler albuterol in mechanically ventilated patients. Chest. 1995;107:210-3.

Martin W, Unutzer J, Szuba MP. Exacerbation of psychosis associated with inhaled albuterol [letter]. J Clin Psychopharmacol. 1995;15:446-7.

Matera MG, Cazzola M, Vinciguerra A, et al. A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease. Pulm Pharmacol. 1995;8:267-71.

Menon K, Sutcliffe T, Klassen TP. A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. J Pediatr. 1995;126:1004-7.

Moayyedi P, Congleton J, Page RL, et al. Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease. Thorax. 1995;50:834-7.

Newman SP. Generic salbutamol metered dose inhalers [letter; comment]. Thorax. 1995;50:590.

Nishimura K, Koyama H, Ikeda A, Sugiura N, Kawakatsu K, Izumi T. The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD. Chest. 1995;107:718-23.

O'Connor J, Kane GC, Tolino M, et al. Inhaled albuterol does not inhibit cellular influx or lung injury produced by segmental antigen challenge in humans. Pulm Pharmacol. 1995;8:237-43.

Oldaeus G, Kubista J, Stahl E. Comparison of Bricanyl Turbuhaler and Ventolin Rotahaler in children with asthma. Ann Allergy Asthma Immunol. 1995;74:34-7.

Reisner C, Kotch A, Dworkin G. Continuous versus frequent intermittent nebulization of albuterol in acute asthma: a randomized, prospective study. Ann Allergy Asthma Immunol. 1995;75:41-7.

Rivington RN, Boulet LP, Cote J, et al. Efficacy of Uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids. Am J Respir Crit Care Med. 1995;151:325-32.

Rodrigo C, Rodrigo G. High-dose MDI salbutamol treatment of asthma in the ED. Am J Emerg Med. 1995;13:21-6.

Schuh S, Johnson DW, Callahan S, et al. Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma. J Pediatr. 1995;126:639-45.

Shorten GD, Dolovich M, Lerman J, Cutz E. Metered-dose inhaler salbutamol-induced tracheal epithelial lesions in intubated rabbits. Effects of the site of administration and time. Chest. 1995;108:1668-72.

Udezue E, D'Souza L, Mahajan M. Hypokalemia after normal doses of neubulized albuterol (salbutamol). Am J Emerg Med. 1995;13:168-71.

Watson JP, Lewis RA. Generic salbutamol metered dose inhalers [letter; comment]. Thorax. 1995;50:590.

Yates DH, Peters MJ, Keatings V, et al. Reduced dose salbutamol in comparison with standard dosage for symptom relief in asthma. Eur Respir J. 1995;8:1847-51.

Avital A, Godfrey S, Schachter J, Springer C. Protective effect of albuterol delivered via a spacer device (Babyhaler) against methacholine induced bronchoconstriction in young wheezy children. Pediatr Pulmonol. 1994;17:281-4.

Bennett JA, Smyth ET, Pavord ID, et al. Systemic effects of salbutamol and salmeterol in patients with asthma. Thorax. 1994;49:771-4.

Carter ER. Albuterol administered by metered-dose inhaler and spacer to young children with wheezing [letter; comment]. Arch Pediatr Adolesc Med. 1994;148:1352-4.

Chapman KR, Kesten S, Szalai JP. Regular vs as-needed inhaled salbutamol in asthma control. Lancet. 1994;343:1379-82.

Chege JK, Chrystyn H. Volumatic usage: some generic salbutamol metered dose inhalers can be used. Thorax. 1994;49:1162-3.

Chhabra SK. A comparison of "closed" and "open" mouth techniques of inhalation of a salbutamol metered-dose inhaler. J Asthma. 1994;31:123-5.

Connett GJ, Warde C, Wooler E, Lenney W. Prednisolone and salbutamol in the hospital treatment of acute asthma. Arch Dis Child. 1994;70:170-3.

Coppola M, Westfall M. Albuterol protocol [letter; comment]. Am J Emerg Med. 1994;12:123-4.

Cukier A, Vargas FS, Teixeira LR, et al. Arrhythmogenic effects of combined orally administered theophylline and albuterol in patients with chronic obstructive pulmonary disease. Braz J Med Biol Res. 1994;27:2869-77.

Cydulka RK, Emerman CL. Effects of combined treatment with glycopyrrolate and albuterol in acute exacerbation of asthma. Ann Emerg Med. 1994;23:270-4.

Garner SS, Wiest DB, Bradley JW. Albuterol delivery by metered-dose inhaler with a pediatric mechanical ventilatory circuit model. Pharmacotherapy. 1994;14:210-4.

Haahtela T, Vidgren M, Nyberg A, et al. A novel multiple dose powder inhaler. Salbutamol powder and aerosol give equal bronchodilatation with equal doses. Ann Allergy. 1994;72:178-82.

Kesten S, Elias M, Cartier A, Chapman KR. Patient handling of a multidose dry powder inhalation device for albuterol. Chest. 1994;105:1077-81.

Libretto SE. A review of the toxicology of salbutamol (albuterol). Arch Toxicol. 1994;68:213-6.

Nelson HS, Loffert DT. Comparison of the bronchodilator response to albuterol administered by the OptiHaler, the AeroChamber, or by metered dose inhaler alone. Ann Allergy. 1994;72:337-40.

Nelson MS. Albuterol [letter; comment]. Am J Emerg Med. 1994;12:123-4.

Newhouse MT, Dolovich MB, Kazim F. Dose-effect relationship of the beta-agonists fenoterol and salbutamol in patients with asthma. Chest. 1994;105:1738-42.

Newnham DM, Lipworth BJ. Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream"). Thorax. 1994;49:762-70.

Nieminen MM, Vidgren M, Laurikainen K, et al. Easyhaler, a novel multiple dose powder inhaler: clinically equivalent to salbutamol metered dose inhaler and easier to use. Respiration. 1994;61:37-41.

Peterfreund RA, Niven RW, Kacmarek RM. Syringe-actuated metered dose inhalers: a quantitative laboratory evaluation of albuterol delivery through nozzle extensions. Anesth Analg. 1994;78:554-8.

Salmeron S, Brochard L, Mal H, et al. Nebulized versus intravenous albuterol in hypercapnic acute asthma. A multicenter, double-blind, randomized study. Am J Respir Crit Care Med. 1994;149:1466-70.

Taylor DR, Sears MR. Regular versus as-needed inhaled salbutamol in asthma control [letter; comment]. Lancet. 1994;344:621.

Vidgren M, Arppe J, Vidgren P, et al. Pulmonary deposition and clinical response of 99mTc-labelled salbutamol delivered from a novel multiple dose powder inhaler. Pharm Res. 1994;11:1320-4.

Weiss SJ, Anand P, Ernst AA, Orgeron D, May WL. Effect of out-of-hospital albuterol inhalation treatments on patient comfort and morbidity. Ann Emerg Med. 1994;24:873-8.

Carter ER, Moffitt DR. Nebulized salbutamol versus racemic epinephrine in the treatment of infants with bronchiolitis [letter; comment]. J Pediatr. 1993;123:491-2.

Castle W, Fuller R, Hall J, Palmer J. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ. 1993;306:1034-7.

Clarke JR, Aston H, Silverman M. Delivery of salbutamol by metered dose inhaler and valved spacer to wheezy infants: effect on bronchial responsiveness. Arch Dis Child. 1993;69:125-9.

Colacone A, Afilalo M, Wolkove N, Kreisman H. A comparison of albuterol administered by metered dose inhaler (and holding chamber) or wet nebulizer in acute asthma. Chest. 1993;104:835-41.

DiGiulio GA, Kercsmar CM, Krug SE, et al. Hospital treatment of asthma: lack of benefit from theophylline given in addition to nebulized albuterol and intravenously administered corticosteroid. J Pediatr. 1993;122:464-9.

Finnerty JP, Howarth PH. Paradoxical bronchoconstriction with nebulized albuterol but not with terbutaline. Am Rev Respir Dis. 1993;148:512-3.

Katz RW, Kelly HW, Crowley MR, et al. Safety of continuous nebulized albuterol for bronchospasm in infants and children. Pediatrics. 1993;92:666-9.

Kerem E, Levison H, Schuh S, et al. Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr. 1993;123:313-7.

Langford SA, Allen MB. Salbutamol output from two jet nebulizers. Respir Med. 1993;87:99-103.

Lin RY, Sauter D, Newman T, et al. Continuous versus intermittent albuterol nebulization in the treatment of acute asthma. Ann Emerg Med. 1993;22:1847-53.

Lin RY, Smith AJ, Hergenroeder P. High serum albuterol levels and tachycardia in adult asthmatics treated with high-dose continuously aerosolized albuterol. Chest. 1993;103:221-5.

Lundback B, Rawlinson DW, Palmer JB. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group. Thorax. 1993;48:148-53.

Malerba M, Politi A, Filippi B, et al. Controlled-release oral salbutamol and cardiac arrhythmias in asthmatic patients [letter]. Chest. 1993;104:987-8.

Malone RA, Hollie MC, Glynn-Barnhart A, Nelson HS. Optimal duration of nebulized albuterol therapy. Chest. 1993;104:1114-8.

Manthous CA, Hall JB, Schmidt GA, Wood LD. Metered-dose inhaler versus nebulized albuterol in mechanically ventilated patients. Am Rev Respir Dis. 1993;148:1567-70.

Oberklaid F, Mellis CM, Souef PN, et al. A comparison of a bodyweight dose versus a fixed dose of nebulised salbutamol in acute asthma in children. Med J Aust. 1993;158:751-3.

Olshaker J, Jerrard D, Barish RA, Brandt G, Hooper F. The efficacy and safety of a continuous albuterol protocol for the treatment of acute adult asthma attacks. Am J Emerg Med. 1993;11:131-3.

Papo MC, Frank J, Thompson AE. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med. 1993;21:1479-86.

Penna AC, Dawson KP. Nebulized salbutamol (albuterol): systemic absorption could be important in achieving bronchodilatation. J Asthma. 1993;30:105-7.

Pfenninger J, Aebi C. Respiratory response to salbutamol (albuterol) in ventilator- dependent infants with chronic lung disease: pressurized aerosol delivery versus intravenous injection. Intensive Care Med. 1993;19:251-5.

Ramoska EA, Henretig F, Joffe M, Spiller HA. Propranolol treatment of albuterol poisoning in two asthmatic patients. Ann Emerg Med. 1993;22:1474-6.

Rudnitsky GS, Eberlein RS, Schoffstall JM, et al. Comparison of intermittent and continuously nebulized albuterol for treatment of asthma in an urban emergency department. Ann Emerg Med. 1993;22:1842-6.

Sanchez I, De Koster J, Holbrow J, Chernick V. The effect of high doses of inhaled salbutamol and ipratropium bromide in patients with stable cystic fibrosis. Chest. 1993;104:842-6.

Scalabrin DM, Naspitz CK. Efficacy and side effects of salbutamol in acute asthma in children: comparison of oral route and two different nebulizer systems. J Asthma. 1993;30:51-9.

Sichletidis L, Daskalopoulou E, Kyriazis G, et al. Comparative efficacy of salbutamol and salmeterol in exercise-induced asthma. J Int Med Res. 1993;21:81-8.

Smyth ET, Pavord ID, Wong CS, et al. Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. BMJ. 1993;306:543-5.

Twentyman OP, Sams VR, Holgate ST. Albuterol and nedocromil sodium affect airway and leukocyte responses to allergen. Am Rev Respir Dis. 1993;147:1425-30.

Vilsvik JS, Ringdal N, Albrektsen T, Holthe S. Comparison of the acceptability of the Ventolin metered-dose inhaler and the Bricanyl Turbuhaler. Ann Allergy. 1993;70:300-4.

Aalto E, Havu M, Kotaniemi J, et al. Comparison of terbutaline Turbuhaler and albuterol chlorofluorocarbon (CFC) inhaler in middle-aged and elderly patients with obstructive lung disease. Ann Allergy. 1992;69:33-6.

Beach JR, Young CL, Stenton SC, et al. A comparison of the speeds of action of salmeterol and salbutamol in reversing methacholine-induced bronchoconstriction. Pulm Pharmacol. 1992;5:133-5.

Bentur L, Canny GJ, Shields MD, et al. Controlled trial of nebulized albuterol in children younger than 2 years of age with acute asthma. Pediatrics. 1992;89:133-7.

Blake KV, Harman E, Hendeles L. Evaluation of a generic albuterol metered-dose inhaler: importance of priming the MDI. Ann Allergy. 1992;68:169-74.

Blake KV, Hoppe M, Harman E, Hendeles L. Relative amount of albuterol delivered to lung receptors from a metered-dose inhaler and nebulizer solution. Bioassay by histamine bronchoprovocation. Chest. 1992;101:309-15.

Bogin RM, Ballard RD. Treatment of nocturnal asthma with pulsed-release albuterol. Chest. 1992;102:362-6.

Bremont F, Moisan V, Dutau G. Continuous subcutaneous infusion of beta 2-agonists in infantile asthma. Pediatr Pulmonol. 1992;12:81-3.

Britton MG, Earnshaw JS, Palmer JB. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group. Eur Respir J. 1992;5:1062-7.

Brown PH, Lenney J, Armstrong S, et al. Breath-actuated inhalers in chronic asthma: comparison of Diskhaler and Turbohaler for delivery of beta-agonists. Eur Respir J. 1992;5:1143-5.

Dal Negro R, Cogo AL, Pomari C, et al. Effects of salbutamol and bitolterol mesilate on pO2 levels in asthmatic patients and healthy volunteers. Arzneimittelforschung. 1992;42:959-61.

Henriksen JM, Agertoft L, Pedersen S. Protective effect and duration of action of inhaled formoterol and salbutamol on exercise-induced asthma in children. J Allergy Clin Immunol. 1992;89:1176-82.

King WD, Holloway M, Palmisano PA. Albuterol overdose: a case report and differential diagnosis. Pediatr Emerg Care. 1992;8:268-71.

Mazza JA, Tashkin DP, Reed CE. Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma. Ann Allergy. 1992;68:267-73.

Meltzer EO, Orgel HA, Ellis EF, et al. Long-term comparison of three combinations of albuterol, theophylline, and beclomethasone in children with chronic asthma. J Allergy Clin Immunol. 1992;90:2-11.

Pearlman DS, Chervinsky P, LaForce C, et al. A comparison of salmeterol with albuterol in the treatment of mild-to- moderate asthma. N Engl J Med. 1992;327:1420-5.

Schuh S, Johnson D, Canny G, et al. Efficacy of adding nebulized ipratropium bromide to nebulized albuterol therapy in acute bronchiolitis. Pediatrics. 1992;90:920-3.

Spring J, Clague J, Ind PW. A comparison of the effect of salmeterol and salbutamol in normal subjects. Br J Clin Pharmacol. 1992;33:139-41.

Taylor IK, O'Shaughnessy KM, Choudry NB, et al. A comparative study in atopic subjects with asthma of the effects of salmeterol and salbutamol on allergen-induced bronchoconstriction, increase in airway reactivity, and increase in urinary leukotriene E4 excretion. J Allergy Clin Immunol. 1992;89:575-83.

Thomas P, Pugsley JA, Stewart JH. Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease. Chest. 1992;101:160-5.

van Lunteren E, Coreno A. Inhaled albuterol powder for pulmonary function testing. Chest. 1992;101:985-8.

Waler JA. Albuterol dosage and acute asthma [letter; comment]. Clin Pediatr (Phila). 1992;31:702.

Bibi H, Montgomery M, Pasterkamp H, Chernick V. Relationship between response to inhaled salbutamol and methacholine bronchial provocation in children with suspected asthma. Pediatr Pulmonol. 1991;10:244-8.

dos Santos JM, Costa H, Stahl E, Wiren JE. Bricanyl Turbuhaler and Ventolin Rotahaler in exercise-induced asthma in children. Allergy. 1991;46:203-5.

Emerman CL, Cydulka RK, Effron D, et al. A randomized, controlled comparison of isoetharine and albuterol in the treatment of acute asthma. Ann Emerg Med. 1991;20:1090-3.

Gongora HC, Wisniewski AF, Tattersfield AE. A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects. Am Rev Respir Dis. 1991;144:626-9.

Gooch MD. Stability of albuterol and tobramycin when mixed for aerosol administration. Respir Care. 1991;36:1387-90.

Harland RW, Miller BG, Varkey B. Urticaria following inhaled albuterol administration by hand-held nebulizer. Respir Care. 1991;36:357-8.

Kornberg AE, Zuckerman S, Welliver JR, et al. Effect of injected long-acting epinephrine in addition to aerosolized albuterol in the treatment of acute asthma in children. Pediatr Emerg Care. 1991;7:1-3.

Kraemer R, Frey U, Sommer CW, Russi E. Short-term effect of albuterol, delivered via a new auxiliary device, in wheezy infants. Am Rev Respir Dis. 1991;144:347-51.

Maesen FP, Costongs R, Smeets JJ, et al. The effect of maximal doses of formoterol and salbutamol from a metered dose inhaler on pulse rates, ECG, and serum potassium concentrations. Chest. 1991;99:1367-73.

Mancebo J, Amaro P, Lorino H, et al. Effects of albuterol inhalation on the work of breathing during weaning from mechanical ventilation. Am Rev Respir Dis. 1991;144:95-100.

Orlowski L, Zychowicz C, Migdal M, Gutkowski P. Effect of salbutamol on specific airway resistance in infants with a history of wheezing. Pediatr Pulmonol. 1991;10:191-4.

Paggiaro PL, Dente FL, Vagaggini B, et al. Salbutamol plus beclomethasone dipropionate, but not salbutamol alone, completely prevent early and late asthmatic responses to allergen. Respir Med. 1991;85:401-6.

Seidenberg J, Mir Y, von der Hardt H. Hypoxaemia after nebulised salbutamol in wheezy infants: the importance of aerosol acidity. Arch Dis Child. 1991;66:672-5.

Stefano JL, Bhutani VK, Fox WW. A randomized placebo-controlled study to evaluate the effects of oral albuterol on pulmonary mechanics in ventilator-dependent infants at risk of developing BPD. Pediatr Pulmonol. 1991;10:183-90.

Taylor RH, Lerman J. High-efficiency delivery of salbutamol with a metered-dose inhaler in narrow tracheal tubes and catheters. Anesthesiology. 1991;74:360-3.

Twentyman OP, Finnerty JP, Holgate ST. The inhibitory effect of nebulized albuterol on the early and late asthmatic reactions and increase in airway responsiveness provoked by inhaled allergen in asthma. Am Rev Respir Dis. 1991;144:782-7.

Vilsvik J, Schaanning J, Stahl E, Holthe S. Comparison between Bricanyl Turbuhaler and Ventolin metered dose inhaler in the treatment of exercise-induced asthma in adults. Ann Allergy. 1991;67:315-8.

Yuksel B, Greenough A. Effect of nebulized salbutamol in preterm infants during the first year of life. Eur Respir J. 1991;4:1088-92.

Barros MJ, Rees PJ. Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction. Respir Med. 1990;84:371-5.

Breeden CC, Safirstein BH. Albuterol and spacer-induced atrial fibrillation. Chest. 1990;98:762-3.

Colacone A, Wolkove N, Stern E, et al. Continuous nebulization of albuterol (salbutamol) in acute asthma. Chest. 1990;97:693-7.

Guarnaccia S, Pasquali M, Acerbis F, et al. Clinico-functional evaluation of flunisolide + salbutamol combination (VAL 679/A) vs salbutamol in pediatric patients. Minerva Pediatr. 1990;42:237-42.

Harris JB, Ahrens RC, Milavetz G, et al. Comparison of the intensity and duration of effects of inhaled bitolterol and albuterol on airway caliber and airway responsiveness to histamine. J Allergy Clin Immunol. 1990;85:1043-9.

James RW, Masters IB. Single breath versus panting technique in salbutamol delivery through a 750 mL spacing device. Pediatr Pulmonol. 1990;8:263-7.

Maesen FP, Smeets JJ, Gubbelmans HL, Zweers PG. Bronchodilator effect of inhaled formoterol vs salbutamol over 12 hours. Chest. 1990;97:590-4.

Pierson WE, LaForce CF, Bell TD, et al. Long-term, double-blind comparison of controlled-release albuterol versus sustained-release theophylline in adolescents and adults with asthma. J Allergy Clin Immunol. 1990;85:618-26.

Schuh S, Canny G, Reisman JJ, et al. Nebulized albuterol in acute bronchiolitis. J Pediatr. 1990;117:633-7.

Schuh S, Reider MJ, Canny G, et al. Nebulized albuterol in acute childhood asthma: comparison of two doses. Pediatrics. 1990;86:509-13.

Self TH, Abou-Shala N, Burns R, et al. Inhaled albuterol and oral prednisone therapy in hospitalized adult asthmatics. Does aminophylline add any benefit? Chest. 1990;98:1317-21.

Shovlin CL, Tam FW. Salbutamol nebuliser and precipitation of critical cardiac ischaemia [letter; comment]. Lancet. 1990;336:1258.

Sur S, Mohiuddin AA, Vichyanond P, Nelson HS. A random double-blind trial of the combination of nebulized atropine methylnitrate and albuterol in nocturnal asthma. Ann Allergy. 1990;65:384-8.

Sykes AP, Ayres JG. A study of the duration of the bronchodilator effect of 12 micrograms and 24 micrograms of inhaled formoterol and 200 micrograms inhaled salbutamol in asthma. Respir Med. 1990;84:135-8.

Ullman A, Hedner J, Svedmyr N. Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis. Am Rev Respir Dis. 1990;142:571-5.

Voss KR, Willsie-Ediger SK, Pyszczynski DR, Nelson KA. Description of a delivery method for continuously aerosolized albuterol in status asthmaticus. J Asthma. 1990;27:37-9.

Anani A, Higgins AJ, Crompton GK. Breath-actuated inhalers: comparison of terbutaline Turbohaler with salbutamol Rotahaler. Eur Respir J. 1989;2:640-2.

Assoufi BK, Hodson ME. High dose salbutamol in chronic airflow obstruction: comparison of nebulizer with Rotacaps. Respir Med. 1989;83:415-20.

Conner WT, Dolovich MB, Frame RA, Newhouse MT. Reliable salbutamol administration in 6- to 36-month-old children by means of a metered dose inhaler and Aerochamber with mask. Pediatr Pulmonol. 1989;6:263-7.

Horn CR, Essex E, Hill P, Cochrane GM. Does urinary salbutamol reflect compliance with the aerosol regimen in patients with asthma? Respir Med. 1989;83:15-8.

Johnson MA, Newman SP, Bloom R, et al. Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma. Efficacy and pulmonary deposition. Chest. 1989;96:6-10.

Malo JL, Ghezzo H, Trudeau C, et al. Duration of action of inhaled terbutaline at two different doses and of albuterol in protecting against bronchoconstriction induced by hyperventilation of dry cold air in asthmatic subjects. Am Rev Respir Dis. 1989;140:817-21.

Price AH, Clissold SP. Salbutamol in the 1980s. A reappraisal of its clinical efficacy. Drugs. 1989;38:77-122.

Ruffin RE, Latimer KM, Crockett AJ, Blight MM. A comparative bronchodilator study of salbutamol and salbutamol sulphate that were administered by metered-dose inhalers. Med J Aust. 1989;150:274-5, 277.

Schuh S, Parkin P, Rajan A, et al. High-versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma. Pediatrics. 1989;83:513-8.

McDonald C, Pover GM, Crompton GK. Evaluation of the combination inhaler of salbutamol and beclomethasone dipropionate in the management of asthma. Curr Med Res Opin. 1988;11:116-22.

O'Callaghan C, Milner AD, Swarbrick A. Nebulised salbutamol does have a protective effect on airways in children under 1 year old. Arch Dis Child. 1988;63:479-83.

Patakas D, Maniki E, Tsara V, Daskalopoulou E. Intermittent and continuous salbutamol rotacaps inhalation in asthmatic patients. Respiration. 1988;54:174-8.

Sly RM, Barbera JM, Middleton HB, Eby DM. Delivery of albuterol aerosol by aerochamber to young children. Ann Allergy. 1988;60:403-6.

Ullman A, Svedmyr N. Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax. 1988;43:674-8.

Habib MP, Campbell SC, Shon BY, Pinnas JL. A comparison of albuterol and metaproterenol nebulizer solutions. Ann Allergy. 1987;58:421-4.

Jenkins SC, Heaton RW, Fulton TJ, Moxham J. Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation. Chest. 1987;91:804-7.

Berkowitz R, Schwartz E, Bukstein D, et al. Albuterol protects against exercise-induced asthma longer than metaproterenol sulfate. Pediatrics. 1986;77:173-8.

Douglas JG, Leslie MJ, Crompton GK, Grant IW. A comparative study of two doses of salbutamol nebulized at 4 and 8 litres per minute in patients with chronic asthma. Br J Dis Chest. 1986;80:55-8.

Easton PA, Jadue C, Dhingra S, Anthonisen NR. A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence. N Engl J Med. 1986;315:735-9.

Laitinen LA, Poppius H. Combination of oxitropium bromide and salbutamol in the treatment of asthma with pressurized aerosols. Br J Dis Chest. 1986;80:179-86.

Newhouse MT, Dolovich MB. Albuterol nebulizer solution for the treatment of asthma [letter]. Ann Allergy. 1986;57:229.

O'Callaghan C, Milner AD, Swarbrick A. Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants. Lancet. 1986;2:1424-5.

Olivenstein R, Wolkove N, Cohen C, et al. A comparison of responses to albuterol delivered by two aerosol devices. Chest. 1986;90:392-5.

Scremin S, Caprioglio L. Treatment of asthma with an extempore combination of a bronchodilator, salbutamol, and a new antihistamine drug, oxatomide. Int J Clin Pharmacol Res. 1986;6:105-11.

Casthely PA, Cottrell JE, Urquhart PA. Comparison of metaproterenol, isoetharine and salbutamol in the relief of methacholine-induced bronchospasm in dogs. Can Anaesth Soc J. 1985;32:112-8.

Douglas JG, Rafferty P, Fergusson RJ, et al. Nebulised salbutamol without oxygen in severe acute asthma: how effective and how safe? Thorax. 1985;40:180-3.

Orgel HA, Kemp JP, Tinkelman DG, Webb DR Jr. Bitolterol and albuterol metered-dose aerosols: comparison of two long-acting beta 2-adrenergic bronchodilators for treatment of asthma. J Allergy Clin Immunol. 1985;75:55-62.

Storms WW, Hudson LD, DeGraff AC, et al. Albuterol nebulizer solution for the treatment of asthma. Ann Allergy. 1985;55:779-82.

Tukiainen P, Salorinne Y. Oxitropium, salbutamol and their combination in asthma. Eur J Respir Dis. 1985;67:31-6.

Repsher LH, Anderson JA, Bush RK, et al. Assessment of tachyphylaxis following prolonged therapy of asthma with inhaled albuterol aerosol. Chest. 1984;85:34-8.

Berezuk GP, Schondelmeyer SW, Seidenfeld JJ, et al. Clinical comparison of albuterol, isoetharine, and metaproterenol given by aerosol inhalation. Clin Pharm. 1983;2:129-34.

Fergusson RJ, Carmichael J, Rafferty P, et al. Nebulized salbutamol in life-threatening asthma: is IPPB necessary? Br J Dis Chest. 1983;77:255-61.

Berg IM, Berg T, Ringqvist I. Salbutamol in the treatment of asthmatic children. A comparison of oral and inhalation therapy alone and in combination. Eur J Respir Dis. 1982;63:305-9.

Dyson AJ, Mackay AD. Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction. Br J Dis Chest. 1980;74:70-7.

Beumer HM. Comparative investigations on pirbuterol, salbutamol and placebo aerosols in bronchial asthma. Int J Clin Pharmacol Biopharm. 1979;17:237-9.

Lenney W, Milner AD, Hiller EJ. Continuous and intermittent salbutamol tablet administration in asthmatic children. Br J Dis Chest. 1979;73:277-81.

Elegbeleye OO, Williams KO, Femi-Pearse D. Comparison of the metabolic effects of salbutamol administered in a one-minute bolus and a continuous infusion in patients with bronchial asthma. Isr J Med Sci. 1978;14:455-8.

Reyes A, Sykes MK, Chakrabarti MK, et al. The effect of salbutamol on hypoxic pulmonary vasoconstriction in dogs. Bull Eur Physiopathol Respir. 1978;14:741-53.

Nelson HS, Raine D Jr, Doner HC, Posey WC. Subsensitivity to the bronchodilator action of albuterol produced by chronic administration. Am Rev Respir Dis. 1977;116:871-8.

Bhatia SP, Davies HJ. Evaluation of tolerance after continuous and prolonged oral administration of salbutamol to asthmatic patients. Br J Clin Pharmacol. 1975;2:463-6.

Snider GL, Laguarda R. Albuterol and isoproterenol aerosols. A controlled study of duration of effect in asthmatic patients. JAMA. 1972;221:682-5.

Compiled 7/30/99. Based on MedLine Update through June, 1999. A Scanlan Bibliography

Company | Contacts | Products | Sales